Skip to main content

Advertisement

Table 3 Pathological Staging after Surgery

From: Neoadjuvant irinotecan, cisplatin, and concurrent radiation therapy with celecoxib for patients with locally advanced esophageal cancer

Stage Total 40 Patients
Complete Response 13 patients (32.5 %)
Microscopic Residual Disease 6 patients (15 %)
Stage I 3 patients (7.5 %)
Stage IIA 4 patients (10 %)
Stage IIB 4 patients (10 %)
Stage III 5 patients (12.5 %)
Stage IVA 3 patients (7.5 %)
Stage IVB or Refused Surgery 2 patients (5 %)